Skip to main content
. 2019 Jun 27;178(1):216–228.e21. doi: 10.1016/j.cell.2019.05.025

Figure S1.

Figure S1

Clinical Trial (VAC057) Volunteer Information and Additional PfRH5 mAb Binding Data, Related to Figure 1

(A) Vaccination details of the three volunteers from which anti-PfRH5FL mAbs were isolated. (B) List of anti-PfRH5 mAb binding properties. Association-rate (Kon), dissociation-rate (Koff) and affinity (KD) are shown. (C) Dot blot showing anti-PfRH5 mAbs binding to parasite-derived PfRH5. PBS, PfRH5FL and a recombinant anti-Ebolavirus IgG1 mAb (α-EBOV) were used as controls.